• Home
  • Policies & Regulations
  • Clinical Trials Protocol Template for Phase II and III Clinical Trials Conducted Under an IND or IDE

Clinical Trials Protocol Template for Phase II and III Clinical Trials Conducted Under an IND or IDE

Investigators conducting phase 2 or 3 clinical trials that require Investigational New Drug applications (IND) or Investigational Device Exemption (IDE) applications can use a NIH-FDA template with instructional and sample text to help write protocols.

Download the Word Version of Final Template.

Investigators are also encouraged to use an electronic protocol-writing tool, developed by the NIH and the Food and Drug Administration, to facilitate the development of phase 2 and 3 clinical trial protocols.

See e-protocol.od.nih.gov for more information.

NC TraCS Institute logo vertical

In partnership with:

Contact Us


Brinkhous-Bullitt, 2nd floor
160 N. Medical Drive
Chapel Hill, NC 27599

919.966.6022
This email address is being protected from spambots. You need JavaScript enabled to view it.

Social


Cite Us


© 2008-2020 The North Carolina Translational and Clinical Sciences (NC TraCS) Institute at The University of North Carolina at Chapel Hill
The content of this website is solely the responsibility of the University of North Carolina at Chapel Hill and does not necessarily represent the official views of the NIH   accessibility | contact